BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 36532033)

  • 1. The different damage patterns of short-, middle- and long-range connections between patients with relapse-remitting multiple sclerosis and neuromyelitis optica spectrum disorder.
    Chen X; Peng Y; Zheng Q; Luo D; Han Y; Luo Q; Zhu Q; Luo T; Li Y
    Front Immunol; 2022; 13():1007335. PubMed ID: 36532033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of probabilistic tractography and tract-based spatial statistics for assessing optic radiation damage in patients with autoimmune inflammatory disorders of the central nervous system.
    Kuchling J; Backner Y; Oertel FC; Raz N; Bellmann-Strobl J; Ruprecht K; Paul F; Levin N; Brandt AU; Scheel M
    Neuroimage Clin; 2018; 19():538-550. PubMed ID: 29984162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuromyelitis optica spectrum disorder and multiple sclerosis: Differentiation by a multimodal approach.
    Ota M; Sato N; Okamoto T; Noda T; Araki M; Yamamura T; Kunugi H
    Mult Scler Relat Disord; 2015 Nov; 4(6):515-20. PubMed ID: 26590657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of diffusion tensor imaging (DTI) tissue characterization parameters in white matter tracts of patients with multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD).
    Chen X; Roberts N; Zheng Q; Peng Y; Han Y; Luo Q; Feng J; Luo T; Li Y
    Eur Radiol; 2024 Jan; ():. PubMed ID: 38175221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progressive brain microstructural damage in patients with multiple sclerosis but not in patients with neuromyelitis optica spectrum disorder: A cross-sectional and follow-up tract-based spatial statistics study.
    Chen X; Roberts N; Zheng Q; Peng Y; Han Y; Luo Q; Zeng C; Wang J; Luo T; Li Y
    Mult Scler Relat Disord; 2021 Oct; 55():103178. PubMed ID: 34384989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enlarged choroid plexus related to cortical atrophy in multiple sclerosis.
    Chen X; Luo D; Zheng Q; Peng Y; Han Y; Luo Q; Zhu Q; Luo T; Li Y
    Eur Radiol; 2023 Apr; 33(4):2916-2926. PubMed ID: 36547675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Grey Matter Atrophy and its Relationship with White Matter Lesions in Patients with Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease, Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder, and Multiple Sclerosis.
    Cortese R; Battaglini M; Prados F; Gentile G; Luchetti L; Bianchi A; Haider L; Jacob A; Palace J; Messina S; Paul F; Marignier R; Durand-Dubief F; de Medeiros Rimkus C; Apostolos Pereira SL; Sato DK; Filippi M; Rocca MA; Cacciaguerra L; Rovira À; Sastre-Garriga J; Arrambide G; Liu Y; Duan Y; Gasperini C; Tortorella C; Ruggieri S; Amato MP; Ulivelli M; Groppa S; Grothe M; Llufriu S; Sepulveda M; Lukas C; Bellenberg B; Schneider R; Sowa P; Celius EG; Pröbstel AK; Granziera C; Yaldizli Ö; Müller J; Stankoff B; Bodini B; Barkhof F; Ciccarelli O; De Stefano N;
    Ann Neurol; 2024 May; ():. PubMed ID: 38780377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disrupted structural network of inferomedial temporal regions in relapsing-remitting multiple sclerosis compared with neuromyelitis optica spectrum disorder.
    Cho EB; Kim D; Jeong B; Shin JH; Chung YH; Kim ST; Kim BJ; Han CE; Min JH
    Sci Rep; 2022 Mar; 12(1):5152. PubMed ID: 35338192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain age gap in neuromyelitis optica spectrum disorders and multiple sclerosis.
    Wei R; Xu X; Duan Y; Zhang N; Sun J; Li H; Li Y; Li Y; Zeng C; Han X; Zhou F; Huang M; Li R; Zhuo Z; Barkhof F; H Cole J; Liu Y
    J Neurol Neurosurg Psychiatry; 2023 Jan; 94(1):31-37. PubMed ID: 36216455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spinal cord and brain atrophy patterns in neuromyelitis optica spectrum disorder and multiple sclerosis.
    Hua T; Fan H; Duan Y; Tian D; Chen Z; Xu X; Bai Y; Li Y; Zhang N; Sun J; Li H; Li Y; Li Y; Zeng C; Han X; Zhou F; Huang M; Xu S; Jin Y; Li H; Zhuo Z; Zhang X; Liu Y
    J Neurol; 2024 Jun; 271(6):3595-3609. PubMed ID: 38558149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential brainstem atrophy patterns in multiple sclerosis and neuromyelitis optica spectrum disorders.
    Lee CY; Mak HK; Chiu PW; Chang HC; Barkhof F; Chan KH
    J Magn Reson Imaging; 2018 Jun; 47(6):1601-1609. PubMed ID: 28990252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relapses after SARS-CoV-2 vaccination in patients with neuromyelitis optica spectrum disorder and multiple sclerosis.
    Kong L; Wang X; Chen H; Shi Z; Lang Y; Zhang Y; Zhou H
    Mult Scler Relat Disord; 2022 Dec; 68():104167. PubMed ID: 36170773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural covariance in subcortical regions in multiple sclerosis and neuromyelitis optica spectrum disorders: An MRI-based study with automated brain volumetry.
    Xie Y; Zhang Y; Yao Y; Liu D; Zhu H; Liu C; Zhu W
    Mult Scler Relat Disord; 2023 Feb; 70():104516. PubMed ID: 36669244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microstructural white matter abnormalities in multiple sclerosis and neuromyelitis optica spectrum disorders: Evaluation by advanced diffusion imaging.
    Kato S; Hagiwara A; Yokoyama K; Andica C; Tomizawa Y; Hoshino Y; Uchida W; Nishimura Y; Fujita S; Kamagata K; Hori M; Hattori N; Abe O; Aoki S
    J Neurol Sci; 2022 May; 436():120205. PubMed ID: 35259556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Next-generation sequencing identifies altered whole blood microRNAs in neuromyelitis optica spectrum disorder which may permit discrimination from multiple sclerosis.
    Keller A; Leidinger P; Meese E; Haas J; Backes C; Rasche L; Behrens JR; Pfuhl C; Wakonig K; Gieß RM; Jarius S; Meder B; Bellmann-Strobl J; Paul F; Pache FC; Ruprecht K
    J Neuroinflammation; 2015 Oct; 12():196. PubMed ID: 26521232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fractional anisotropy helps to differentiate the optic nerve impairment between neuromyelitis optica spectrum disorders and multiple sclerosis.
    Xie Y; Zhang Y; Yao Y; Liu D; Chen B; Zhu W
    Eur Radiol; 2022 Sep; 32(9):6158-6166. PubMed ID: 35420298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural and functional hippocampal alterations in Multiple sclerosis and neuromyelitis optica spectrum disorder.
    Zheng F; Li Y; Zhuo Z; Duan Y; Cao G; Tian D; Zhang X; Li K; Zhou F; Huang M; Li H; Li Y; Zeng C; Zhang N; Sun J; Yu C; Han X; Hallar S; Barkhof F; Liu Y
    Mult Scler; 2022 Apr; 28(5):707-717. PubMed ID: 34379008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optical Coherence Tomography in Neuromyelitis Optica spectrum disorder and Multiple Sclerosis: A population-based study.
    Ashtari F; Ataei A; Kafieh R; Khodabandeh Z; Barzegar M; Raei M; Dehghani A; Mansurian M
    Mult Scler Relat Disord; 2021 Jan; 47():102625. PubMed ID: 33227631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optical Coherence Tomography Reveals Distinct Patterns of Retinal Damage in Neuromyelitis Optica and Multiple Sclerosis.
    Schneider E; Zimmermann H; Oberwahrenbrock T; Kaufhold F; Kadas EM; Petzold A; Bilger F; Borisow N; Jarius S; Wildemann B; Ruprecht K; Brandt AU; Paul F
    PLoS One; 2013; 8(6):e66151. PubMed ID: 23805202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deep gray matter atrophy in neuromyelitis optica spectrum disorder and multiple sclerosis.
    Hyun JW; Park G; Kwak K; Jo HJ; Joung A; Kim JH; Lee SH; Kim S; Lee JM; Kim SH; Kim HJ
    Eur J Neurol; 2017 Feb; 24(2):437-445. PubMed ID: 28009104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.